[FG] Heininger Ulrich

Grant, Rebecca et al. (2024) ‘In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland’, Clinical Infectious Diseases [Preprint]. Available at: https://doi.org/10.1093/cid/ciae558.

Villaverde, Serena et al. (2024) ‘Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus’, Pediatric Infectious Disease Journal [Preprint]. Available at: https://doi.org/10.1097/inf.0000000000004583.

Meyer Sauteur, Patrick M. et al. (2024) ‘Ongoing disruption of RSV epidemiology in children in Switzerland’, The Lancet Regional Health - Europe, 45, p. 101050. Available at: https://doi.org/10.1016/j.lanepe.2024.101050.

Laura Heeb et al. (2024) ‘Borrelia burgdorferi infections in children and adolescents in Switzerland – a seroprevalence study 2023/2024 (BOBUINCA)’, Infection [Preprint]. Available at: https://doi.org/10.1007/s15010-024-02387-7.

Golhen, K. et al. (2024) ‘Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg’, Pharmaceutics, 16(9), p. 1186. Available at: https://doi.org/10.3390/pharmaceutics16091186.

Vancauwenberghe, Laure et al. (2024) ‘Swiss COVID-19 hospital surveillance: an in-depth analysis of the factors associated with hospital readmission dynamics in community-acquired COVID-19 cases’, Swiss Medical Weekly, 154(9), p. 3773. Available at: https://doi.org/10.57187/s.3773.

Erlacher, R. et al. (2024) ‘Are Invasive Group A Streptococcal Infections Preventable by Antibiotic Therapy?: A Collaborative Retrospective Study’, Pediatric Infectious Disease Journal [Preprint]. Available at: https://doi.org/10.1097/inf.0000000000004403.

Schmid, Patrizia et al. (2024) ‘Management of pediatric tularemia in Switzerland and Finland – 2004-2021. Supplementum 277: Abstracts of the of the annual meeting of the Swiss Society of Paediatrics’, Swiss Medical Weekly, 154(5), p. 4002. Available at: https://doi.org/10.57187/s.4002.

Weber, S. et al. (2024) ‘Clinical Characteristics and Management of Children and Adolescents Hospitalized With Pyomyositis’, Pediatric Infectious Disease Journal [Preprint]. Available at: https://doi.org/10.1097/inf.0000000000004382.

Blanchard-Rohner, Geraldine et al. (2024) ‘COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children’, Pediatric Infectious Disease Journal, 43(4), pp. 361–364. Available at: https://doi.org/10.1097/inf.0000000000004206.

Schöbi, Nina et al. (2024) ‘Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland’, BMJ Open, 14(4), p. e078137. Available at: https://doi.org/10.1136/bmjopen-2023-078137.

Wurm, Juliane et al. (2024) ‘Clinical and Laboratory Biomarkers as Predictors of Severity in Pediatric Inflammatory Multisystem Syndrome-temporally Associated With SARS-CoV-2: Data From a Prospective Nationwide Surveillance Study in Switzerland’, Pediatric Infectious Disease Journal [Preprint]. Available at: https://doi.org/10.1097/inf.0000000000004332.

Meyer Sauteur, Patrick M et al. (2024) ‘Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae’, The Lancet Microbe [Preprint]. Available at: https://doi.org/10.1016/s2666-5247(23)00406-8.

Andre, Maya C. et al. (2024) ‘Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial’, eClinicalMedicine, 67. Available at: https://doi.org/10.1016/j.eclinm.2023.102358.

Buettcher, Michael et al. (2024) ‘Tularemia on the rise in Switzerland? A one health approach is needed!’, Infection, null. Available at: https://doi.org/10.1007/s15010-024-02218-9.

Meyer Sauteur, Patrick M et al. (2024) ‘Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions’, The Lancet Microbe, 5, pp. e100–e101. Available at: https://doi.org/10.1016/s2666-5247(23)00344-0.

Ulziibat, M. et al. (2024) ‘Microbiological Spectrum of Osteoarticular Infections and Their Management in Mongolian Children’, Global Pediatric Health, 11. Available at: https://doi.org/10.1177/2333794x241298801.

Weber, S. et al. (2024) ‘Clinical Characteristics and Management of Children and Adolescents Hospitalized With Pyomyositis’, The Pediatric infectious disease journal [Preprint]. Available at: https://doi.org/10.1097/INF.0000000000004382.

Wurm, Juliane et al. (2024) ‘The changing clinical presentation of COVID-19 in children during the course of the pandemic’, Acta Paediatrica, International Journal of Paediatrics. 16.12.2023, 113(4), pp. 771–777. Available at: https://doi.org/10.1111/apa.17061.

Mattatia, Chantal et al. (2023) ‘Seroepidemiology of human tularemia – systematic review and metaanalysis of seroprevalence studies’, Open Forum Infectious Diseases [Preprint]. Available at: https://doi.org/10.1093/ofid/ofad636.

Meyer Sauteur PM, Beeton ML and ESGMAC the ESGMAC MAPS study group (2023) ‘Mycoplasma pneumoniae: gone forever?’, 4(10). Available at: https://doi.org/10.1016/s2666-5247(23)00182-9.

Endrich, O. et al. (2023) ‘Sensitivity of ICD coding for sepsis in children—a population-based study’, Intensive Care Medicine – Paediatric and Neonatal, 1(1). Available at: https://doi.org/10.1007/s44253-023-00006-1.

Buettcher, M. et al. (2023) ‘Paediatric tularemia in Europe - Two countries: Different vectors and epidemiology . Supplementum 267: Abstracts of the annual meeting of the Swiss Society of Paediatrics’, Swiss Medical Weekly, 153(6), p. 40104. Available at: https://doi.org/10.57187/smw.2023.40104.

Büttcher, M., Kahlert, C.R. and Heininger, U. (2023) ‘Management der Borreliose in der Pädiatrie’, Paediatrica, 34(1). Available at: https://doi.org/10.35190/paediatrica.d.2023.1.6.

Büttcher, M., Kahlert, C.R. and Heininger, U. (2023) ‘Prise en charge de la borréliose en pédiatrie’, Paediatrica, 34(1). Available at: https://doi.org/10.35190/paediatrica.f.2023.1.6.

Buonsenso D et al. (2023) ‘Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study.’, Thorax, 78(3), pp. 288–296. Available at: https://doi.org/10.1136/thorax-2022-218929.

Portmann L et al. (2023) ‘Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.’, JAMA network open, 6(2), p. e2255599. Available at: https://doi.org/10.1001/jamanetworkopen.2022.55599.

Buettcher, M and Marquez, L (2023) ‘Toxoplasmosis ESPID Education Online Course: Congenital and Perinatal Infections’, ESPID Education Online Course: Congenital and Perinatal Infections. Available at: https://education.espid.org/espid/2022/congenital-and-perinatal-infection-course/350945/faculty.presenters.module.1.introduction.html?f=menu%3D24%2Abrowseby%3D3%2Asortby%3D2%2Ace_id%3D2216%2Amarker%3D1673%2Afeatured%3D18019%2Ashow_banner_in_top_panel%3D1 .

Fritschi, N. et al. (2023) ‘Ratios from full blood count as markers for TB diagnosis, treatment, prognosis: a systematic review’, International Journal of Tuberculosis and Lung Disease, 27, pp. 822–832. Available at: https://doi.org/10.5588/ijtld.22.0598.

Kissling, Mirjam et al. (2023) ‘Monocyte, Lymphocyte and Neutrophil Ratios - Easy-to-Use Biomarkers for the Diagnosis of Pediatric Tuberculosis’, in -. - (-), pp. 520–527. Available at: https://doi.org/10.1097/inf.0000000000003901.

Ménétrey, A et al. (2023) ‘Vaccine Hesitancy in Central Switzerland: Identifying and Characterizing Undervaccinated Children in a Pediatric Emergency Department. ’, Pediatric Reports [Preprint]. Available at: https://doi.org/10.3390/pediatric15040064.

Schütz SD et al. (2023) ‘Phylogeography of Francisella tularensis subspecies holarctica and epidemiology of tularemia in Switzerland.’, Frontiers in microbiology, 14, p. 1151049. Available at: https://doi.org/10.3389/fmicb.2023.1151049.

Uka, Anita et al. (2023) ‘Cardiac involvement in children with paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): data from a prospective nationwide surveillance study’, Swiss Medical Weekly, 153. Available at: https://doi.org/10.57187/smw.2023.40092.

Welzel, Tatjana et al. (2023) ‘Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial’, The Lancet Child and Adolescent Health, 7, pp. 238–248. Available at: https://doi.org/10.1016/s2352-4642(23)00020-2.

Büttcher M., Kahlert C.R. and Heininger U. (2023) ‘Management der Borreliose in der Pädiatrie’, Paediatrica, p. 14.

Abu-Raya, B. et al. (2022) ‘Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative’, Vaccines, 10(12). Available at: https://doi.org/10.3390/vaccines10121990.

Sauteur P.M.M. et al. (2022) ‘Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?’, The Lancet Microbe, 3(12), p. e897. Available at: https://doi.org/10.1016/s2666-5247(22)00190-2.

Buettcher M. and Ritz N. (2022) ‘11/m—Pain in the left leg and limping after bicycle crash: Preparation for the medical specialist examination: part 92 11/m mit Schmerzen im linken Bein und Hinken nach Fahrradsturz: Vorbereitung auf die Facharztprüfung: Fall 92’, Monatsschrift fur Kinderheilkunde, 170, pp. 491–495. Available at: https://doi.org/10.1007/s00112-022-01602-9.

Buhl D. et al. (2022) ‘Corrigendum: Specifically increased rate of infections in children post measles in a high resource setting(Front. Pediatr., (2022), 10, (896086), 10.3389/fped.2022.896086)’, Frontiers in Pediatrics, 10. Available at: https://doi.org/10.3389/fped.2022.1005990.

Fabienne N. Jaeger et al. (2022) ‘Prise en charge médicale des ­réfugiés mineurs d’Ukraine’, Bull Med Suisses. 03.08.2022, (103(3132)), p. 3. Available at: https://doi.org/10.4414/bms.2022.20927.

Jger, F.N. et al. (2022) ‘Junge Flchtlinge optimal versorgen’, Schweizerische Ärztezeitung [Preprint]. Available at: https://doi.org/10.4414/saez.2022.20927.

Buhl D. et al. (2022) ‘Specifically Increased Rate of Infections in Children Post Measles in a High Resource Setting’, Frontiers in Pediatrics, 10. Available at: https://doi.org/10.3389/fped.2022.896086.

Heininger U (2022) ‘Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23):3120-3130.’, 40(26). Available at: https://doi.org/10.1016/j.vaccine.2022.04.075.

Heininger U and Plotkin S (2022) ‘Titerphilia - The Irresistible Urge to Measure Postimmunization Antibody Values.’, The Pediatric infectious disease journal, 41(6), pp. 490–491. Available at: https://doi.org/10.1097/inf.0000000000003519.

Kapp, A. et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome . Supplementum 258: Abstracts of the annual meeting 2022 of the Swiss Society of Paediatrics’, Swiss Medical Weekly, 152(2122), p. w30203. Available at: https://doi.org/10.4414/smw.2022.w30203.

Zimmermann P et al. (2022) ‘Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study’, Swiss Medical Weekly, 152(21-22). Available at: https://doi.org/10.4414/smw.2022.w30185.

Meyer Sauteur P.M. et al. (2022) ‘Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021’, Eurosurveillance, 27(19). Available at: https://doi.org/10.2807/1560-7917.es.2022.27.19.2100746.

Buettcher M (2022) ‘Borrelial lymphocytoma presentations of the ear.’, Archives of disease in childhood, 107(5), p. 490. Available at: https://doi.org/10.1136/archdischild-2021-322652.

Yap N et al. (2022) ‘The Impact of Australian Childhood Vaccination Mandates on Immunization Specialists and Their Interactions With Families.’, The Pediatric infectious disease journal, 41(5), pp. e188–e193. Available at: https://doi.org/10.1097/inf.0000000000003490.

Uka A et al. (2022) ‘Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study’, European Journal of Pediatrics, 181(3), pp. 1245–1255. Available at: https://doi.org/10.1007/s00431-021-04276-9.

Uka A et al. (2022) ‘Correction to: Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study (European Journal of Pediatrics, (2022), 181, 3, (1245-1255), 10.1007/s00431-021-04276-9)’, European Journal of Pediatrics, 181(3), p. 1257. Available at: https://doi.org/10.1007/s00431-021-04359-7.

Jog P et al. (2022) ‘Pertussis in Asia: Recent country-specific data and recommendations.’, 40(8). Available at: https://doi.org/10.1016/j.vaccine.2021.12.004.

Heininger U (2022) ‘Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(3), pp. 562–563. Available at: https://doi.org/10.1093/cid/ciaa643.

Baumann, Philipp et al. (2022) ‘The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections’, PLoS ONE, 17. Available at: https://doi.org/10.1371/journal.pone.0264305.

Bruningk, Sarah C. et al. (2022) ‘Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area’, Virus Evolution, 8(1), p. veac002. Available at: https://doi.org/10.1093/ve/veac002.

Büttcher, M. et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Padiatrische Praxis, 97, pp. 432–448.

Büttcher, M. et al. (2022) ‘Uninary tract infections in children and adolescents – recommendations for the general and hospital paediatrician/practitioner’, Internistische Praxis, 66, pp. 100–116.

Fröhlich GM et al. (2022) ‘Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.’, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(1). Available at: https://doi.org/10.2807/1560-7917.es.2022.27.1.2001848.

Golhen K et al. (2022) ‘Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.’, Frontiers in medicine, 9, p. 944208. Available at: https://doi.org/10.3389/fmed.2022.944208.

Jaeger, F. N. et al. (2022) ‘Paediatric refugees from Ukraine: guidance for health care providers’, Swiss Med Wkly, 152(21-22), p. w30200. Available at: https://doi.org/10.4414/smw.2022.w30200.

Paioni, Paolo et al. (2022) ‘Swiss recommendations on perioperative antimicrobial prophylaxis in children’, Swiss Medical Weekly, 152. Available at: https://doi.org/10.4414/smw.2022.w30230.

Welzel T et al. (2022) ‘Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.’, Frontiers in pediatrics, 10, p. 905046. Available at: https://doi.org/10.3389/fped.2022.905046.

A Kapp et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz. Luzern: Swiss Medical Weekly (Pädiatrie Schweiz), p. 1.

Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Pädiatrische Praxis, (Band 97/3), pp. 432–448.

Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Internistische Praxis [Preprint], (Band 066/01).

Pawaskar M et al. (2021) ‘Economic burden of varicella in Europe in the absence of universal varicella vaccination.’, BMC public health, 21(1), p. 2312. Available at: https://doi.org/10.1186/s12889-021-12343-x.

Jaboyedoff M et al. (2021) ‘SwissPedData: Standardising hospital records for the benefit of paediatric research.’, Swiss medical weekly, 151, p. w30069. Available at: https://doi.org/10.4414/smw.2021.w30069.

Zumstein J, Heininger U and Swiss Paediatric Surveillance Unit (SPSU) (2021) ‘Decline of pertussis in hospitalised children following the introduction of immunisation in pregnancy - results from a nationwide, prospective surveillance study, 2013-2020.’, Swiss medical weekly, 151, p. w30064. Available at: https://doi.org/10.4414/smw.2021.w30064.

Lienert F. et al. (2021) ‘Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients’, BMC Infectious Diseases, 21(1). Available at: https://doi.org/10.1186/s12879-020-05586-3.

Heyne-Pietschmann M et al. (2021) ‘Newborns with Bloody Stools-At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship.’, Antibiotics (Basel, Switzerland), 10(12). Available at: https://doi.org/10.3390/antibiotics10121467.

Rakic M et al. (2021) ‘Clinical data for paediatric research: the Swiss approach : Proceedings of the National Symposium in Bern, Switzerland, Dec 5-6, 2019.’, BMC proceedings, 15(Suppl 13), p. 19. Available at: https://doi.org/10.1186/s12919-021-00226-3.

Roelens, M. et al. (2021) Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.09.14.21263153.

Heininger U. (2021) ‘Pertussis-like illness is not the same as pertussis’, Jornal de Pediatria, 97(5), pp. 471–472. Available at: https://doi.org/10.1016/j.jped.2021.02.001.

von Hammerstein AL et al. (2021) ‘Interseasonal RSV infections in Switzerland - rapid establishment of a clinician-led national reporting system (RSV EpiCH).’, Swiss medical weekly, 151, p. w30057. Available at: https://doi.org/10.4414/smw.2021.w30057.

Maximiano Sousa F et al. (2021) ‘Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.’, Swiss medical weekly, 151, p. w20547. Available at: https://doi.org/10.4414/smw.2021.20547.

Heininger U. (2021) ‘Efficacy of single-dose Ad26.CoV2.s vaccine against covid-19’, New England Journal of Medicine, 385(3), p. 288. Available at: https://doi.org/10.1056/nejmc2107809.

Heininger U. et al. (2021) ‘Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland’, Pediatric Infectious Disease Journal, 40(6), pp. E217–E221. Available at: https://doi.org/10.1097/inf.0000000000003136.

Schmid H. and Heininger U. (2021) ‘Posttreatment Lyme Disease Syndrome-What It Might Be and What It Is Not’, Pediatric Infectious Disease Journal, 40(5), pp. S31–S34. Available at: https://doi.org/10.1097/inf.0000000000002772.

Buettcher M and Imbimbo C (2021) ‘Ulceroglandular Tularemia.’, The New England journal of medicine, 384(14), p. 1349. Available at: https://doi.org/10.1056/nejmicm2031676.

Buettcher M et al. (2021) ‘Swiss consensus recommendations on urinary tract infections in children.’, European journal of pediatrics, 180(3), pp. 663–674. Available at: https://doi.org/10.1007/s00431-020-03714-4.

Buettcher M et al. (2021) ‘Correction to: Swiss consensus recommendations on urinary tract infections in children.’, 180(3). Available at: https://doi.org/10.1007/s00431-020-03820-3.

Feng Y. et al. (2021) ‘Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative’, The Lancet Regional Health - Western Pacific, 8. Available at: https://doi.org/10.1016/j.lanwpc.2021.100098.

Thiabaud A et al. (2021) ‘Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland.’, Swiss medical weekly, 151, p. w20475. Available at: https://doi.org/10.4414/smw.2021.20475.

Schmid Hanna et al. (2021) ‘Preventive measures for accompanying caregivers of children in paediatric health care during the COVID-19 pandemic-walking an ethical tightrope.’, Clinical Microbiology and Infection. 01.02.2021, 27(5), pp. 668–670. Available at: https://doi.org/10.1016/j.cmi.2021.01.023.

Heininger U (2021) ‘Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(3), p. 534. Available at: https://doi.org/10.1093/cid/ciaa642.

Kohns Vasconcelos, M. et al. (2021) ‘Strikingly decreased community-acquired pneumonia admissions in children despite open schools and day-care facilities in Switzerland’, The Pediatric infectious disease journal, 40(4), pp. e171–e172. Available at: https://doi.org/10.1097/inf.0000000000003026.

Roelens, M. et al. (2021) ‘Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)’, Swiss Med Wkly, 151, p. w30105. Available at: https://doi.org/10.4414/smw.2021.w30105.

Uka, A. et al. (2021) ‘Factors Associated with Hospital and Intensive Care Admission in Paediatric SARS-CoV-2 Infection: A Prospective Nationwide Observational Cohort Study’, SSRN Electronic Journal [Preprint]. Available at: https://doi.org/10.2139/ssrn.3823127.

Zihlmann-Ji J et al. (2021) ‘Reduction of Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis in Late-Preterm and Term Newborns After Implementation of a Procalcitonin-Guided Algorithm: A Population-Based Study in Central Switzerland.’, Frontiers in pediatrics, 9, p. 702133. Available at: https://doi.org/10.3389/fped.2021.702133.

Zumstein J, Heininger U and for the Swiss Paediatric Surveillance Unit (2021) ‘Clinical and Epidemiologic Characteristics of Pertussis in Hospitalized Children: A Prospective and Standardized Long-term Surveillance Study.’, The Pediatric infectious disease journal, 40(1), pp. 22–25. Available at: https://doi.org/10.1097/inf.0000000000002904.

AM Peter, L Simma and M Buettcher (2021) ‘Headache and meningism without a cough-Tuberculosis?’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz- Jahrestagung 2021. Fribourg: SWISS MEDICAL WEEKLY (Pädiatrie Schweiz- Jahrestagung 2021), p. 1.

A Stebler, M Pfister and M Buettcher (2021) ‘Scabies management in children in Switzerland’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz - Jahrestagung 2021. Fribourg: SWISS MEDICAL WEEKLY (Pädiatrie Schweiz - Jahrestagung 2021), p. 1.

B Schaub et al. (2021) ‘Presumptive foodborne botulism in a 5-month-old infant caused by home-made food’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz Jahrestagung 2021. Fribourg: SWISS MEDICAL WEEKLY (Pädiatrie Schweiz Jahrestagung 2021), p. 1.

Büttcher M and König A (2021) ‘Was ist bei Bissverletztungen im Kindes- und Jugendalter zu tun?.’, Pädiatrie. Schweizer Fortbildungszeitschrift für Pädiater und Allgemeinärzte [Preprint], (5).

C Imbimbo, P Friderich and M Buettcher (2021) ‘Tularemia on the rise in Switzerland-children compared to adults’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz Jahrestagung 2021. Fribourg: SWISS MEDICAL WEEKLY (Pädiatrie Schweiz Jahrestagung 2021), p. 1.

Büttcher M. (2020) ‘Konsensus Empfehlungen zur Behandlung von Harnwegsinfektionen bei Kindern und Jugendlichen in der Schweiz – 2020’, Paediatrica. 25.12.2020, 31. Available at: https://cdn.paediatrieschweiz.ch/production/uploads/2020/12/31_4_2020_8_de.pdf.

Tin Tin Htar M et al. (2020) ‘Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.’, Vaccine, 38 Suppl 2, pp. B31–B37. Available at: https://doi.org/10.1016/j.vaccine.2019.08.078.

Borghesi A et al. (2020) ‘Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(10), pp. e614–e623. Available at: https://doi.org/10.1093/cid/ciaa290.

Noguera-Julian A et al. (2020) ‘Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(10), pp. 2561–2569. Available at: https://doi.org/10.1093/cid/ciz1138.

Thiabaud, A. et al. (2020) SARS-CoV-2/COVID-19 hospitalised patients in Switzerland: a prospective cohort profile. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2020.12.10.20246884.